Continuous subcutaneous insulin infusion (CSII) in the management of diabetic lipodystrophy: a case report.
A case of diabetic lipodystrophy which showed an improvement after continuous subcutaneous insulin infusion into lipodystrophic areas is reported. The authors feel that this therapeutic regimen could be useful when conventional treatments (the injection of regular purified insulin or dexamethasone-insulin mixtures in the area of the lesion) have failed to obtain good results.
Cimino
A
A
Valentini
U
U
Rotondi
A
A
Radaeli
E
E
Giustina
G
G
D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000627:therapeutic use*; D008060:Lipodystrophy / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged
D001786:Blood Glucose; D007328:Insulin